A Danish company has confirmed Serbian tennis star Novak Djokovic, recently deported from Australia due to his coronavirus vaccine status, is a co-founder and majority shareholder of a biotech firm developing a Covid treatment.
The Chief executive of QuantBioRes, Ivan Loncarevic, told AFP, “He is one of the founders of my company we founded in June 2020. We aim to develop a new technology to fight viruses and resistant bacteria and we decided to use Covid as a showcase, if we succeed with Covid, we will succeed with other viruses.”
According to information publicly available in the Danish business register, 34-year-old Djokovic and his wife, Jelena, together hold a stake of 80 percent in QuantBioRes, which employs a workforce of around 20 in Denmark, Slovenia, Australia and Britain.
QuantBioRes is planning to launch clinical trials in the UK in the summer.
The unvaccinated men’s world number one flew out of Melbourne on Sunday after he failed in a last-gasp court bid to stay and play in the opening Grand Slam of the year, where he was targeting a record 21st major title.